{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T06:28:46Z","timestamp":1788848926000,"version":"build-2803163510"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"PHS","award":["MH081843"],"award-info":[{"award-number":["MH081843"]}]},{"name":"PHS","award":["DA000389"],"award-info":[{"award-number":["DA000389"]}]},{"name":"PHS","award":["MH08138"],"award-info":[{"award-number":["MH08138"]}]},{"name":"Wisconsin Institutes of Discovery"},{"name":"University of Wisconsin Graduate School"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1016\/j.neuropharm.2012.07.005","type":"journal-article","created":{"date-parts":[[2012,7,11]],"date-time":"2012-07-11T10:32:51Z","timestamp":1342002771000},"page":"321-328","source":"Crossref","is-referenced-by-count":36,"special_numbering":"C","title":["A selective dopamine reuptake inhibitor improves prefrontal cortex-dependent cognitive function: Potential relevance to attention deficit hyperactivity disorder"],"prefix":"10.1016","volume":"64","author":[{"given":"Brooke E.","family":"Schmeichel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank P.","family":"Zemlan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig W.","family":"Berridge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2012.07.005_bib1","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1744-9081-1-2","article-title":"Methylphenidate improves prefrontal cortical cognitive function through alpha2 adrenoceptor and dopamine D1 receptor actions: relevance to therapeutic effects in attention deficit hyperactivity disorder","volume":"1","author":"Arnsten","year":"2005","journal-title":"Behav. Brain Funct."},{"key":"10.1016\/j.neuropharm.2012.07.005_bib2","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.pbb.2011.01.020","article-title":"Catecholamine influences on prefrontal cortical function: relevance to treatment of attention deficit\/hyperactivity disorder and related disorders","volume":"99","author":"Arnsten","year":"2011","journal-title":"Pharmacol. Biochemistry, and Behavior"},{"issue":"Suppl. 1","key":"10.1016\/j.neuropharm.2012.07.005_bib3","doi-asserted-by":"crossref","first-page":"i6","DOI":"10.1093\/cercor\/bhm033","article-title":"Catecholamine and second messenger influences on prefrontal cortical networks of \u201crepresentational knowledge\u201d: a rational bridge between genetics and the symptoms of mental illness","volume":"17","author":"Arnsten","year":"2007","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.neuropharm.2012.07.005_bib4","doi-asserted-by":"crossref","first-page":"I","DOI":"10.1016\/j.jpeds.2009.01.018","article-title":"The emerging neurobiology of attention deficit hyperactivity disorder: the key role of the prefrontal association cortex","volume":"154","author":"Arnsten","year":"2009","journal-title":"J.\u00a0Pediatr."},{"key":"10.1016\/j.neuropharm.2012.07.005_bib5","doi-asserted-by":"crossref","first-page":"e101","DOI":"10.1016\/j.biopsych.2010.06.023","article-title":"Psychostimulants as cognitive enhancers: the prefrontal cortex, catecholamines, and attention-deficit\/hyperactivity disorder","volume":"69","author":"Berridge","year":"2011","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.07.005_bib6","doi-asserted-by":"crossref","first-page":"6999","DOI":"10.1523\/JNEUROSCI.16-21-06999.1996","article-title":"Enhancement of behavioral and electroencephalographic indices of waking following stimulation of noradrenergic beta-receptors within the medial septal region of the basal forebrain","volume":"16","author":"Berridge","year":"1996","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.07.005_bib7","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1037\/0735-7044.115.1.165","article-title":"Differential sensitivity to the wake-promoting actions of norepinephrine within the medial preoptic area and the substantia innominata","volume":"115","author":"Berridge","year":"2001","journal-title":"Behav. Neurosci."},{"key":"10.1016\/j.neuropharm.2012.07.005_bib8","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/syn.10131","article-title":"Relationship between low-dose amphetamine-induced arousal and extracellular norepinephrine and dopamine levels within prefrontal cortex","volume":"46","author":"Berridge","year":"2002","journal-title":"Synapse"},{"key":"10.1016\/j.neuropharm.2012.07.005_bib9","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0306-4522(00)00047-6","article-title":"Contrasting effects of noradrenergic beta-receptor blockade within the medial septal area on forebrain electroencephalographic and behavioral activity state in anesthetized and unanesthetized rat","volume":"97","author":"Berridge","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2012.07.005_bib10","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S0306-4522(99)00271-7","article-title":"Amphetamine acts within the medial basal forebrain to initiate and maintain alert waking","volume":"93","author":"Berridge","year":"1999","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2012.07.005_bib11","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.biopsych.2006.04.022","article-title":"Methylphenidate preferentially increases catecholamine neurotransmission within the prefrontal cortex at low doses that enhance cognitive function","volume":"60","author":"Berridge","year":"2006","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.07.005_bib12","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.biopsych.2011.07.022","article-title":"Differential sensitivity to psychostimulants across prefrontal cognitive tasks: differential involvement of Noradrenergic \u03b11- vs. \u03b12-receptors","volume":"71","author":"Berridge","year":"2012","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.07.005_bib13","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1038\/sj.npp.1301159","article-title":"Neural substrates of psychostimulant-induced arousal","volume":"31","author":"Berridge","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2012.07.005_bib14","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1001\/archgenpsychiatry.2007.16","article-title":"Functional magnetic resonance imaging of methylphenidate and placebo in attention-deficit\/hyperactivity disorder during the multi-source interference task","volume":"65","author":"Bush","year":"2008","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.07.005_bib15","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S0893-133X(02)00346-9","article-title":"Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in attention deficit\/hyperactivity disorder","volume":"27","author":"Bymaster","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2012.07.005_bib16","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1111\/j.1471-4159.1990.tb04599.x","article-title":"Blockade of the noradrenaline carrier increases extracellular dopamine concentrations in the prefrontal cortex: evidence that dopamine is taken up in\u00a0vivo by noradrenergic terminals","volume":"55","author":"Carboni","year":"1990","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2012.07.005_bib17","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/j.1471-4159.2005.03556.x","article-title":"Cumulative effect of norepinephrine and dopamine carrier blockade on extracellular dopamine increase in the nucleus accumbens shell, bed nucleus of stria terminalis and prefrontal cortex","volume":"96","author":"Carboni","year":"2006","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2012.07.005_bib18","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/nrn896","article-title":"Neuroscience of attention-deficit\/hyperactivity disorder: the search for endophenotypes","volume":"3","author":"Castellanos","year":"2002","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2012.07.005_bib19","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.biopsych.2007.03.003","article-title":"Atomoxetine improved response inhibition in adults with attention deficit\/hyperactivity disorder","volume":"62","author":"Chamberlain","year":"2007","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.07.005_bib20","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1523\/JNEUROSCI.4778-04.2005","article-title":"Identification of a dopamine transporter ligand that blocks the stimulant effects of cocaine","volume":"25","author":"Desai","year":"2005","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.07.005_bib21","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.biopsych.2008.04.037","article-title":"Cognition-enhancing doses of methylphenidate preferentially increase prefrontal cortex neuronal responsiveness","volume":"64","author":"Devilbiss","year":"2008","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.07.005_bib22","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1017\/S0954579405050388","article-title":"Attention-deficit disorder (attention-deficit\/hyperactivity disorder without hyperactivity): a neurobiologically and behaviorally distinct disorder from attention-deficit\/hyperactivity disorder (with hyperactivity)","volume":"17","author":"Diamond","year":"2005","journal-title":"Dev. Psychopathol."},{"key":"10.1016\/j.neuropharm.2012.07.005_bib23","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1007\/s002130050284","article-title":"Effects of methylphenidate on spatial working memory and planning in healthy young adults","volume":"131","author":"Elliott","year":"1997","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2012.07.005_bib24","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1002\/cne.20946","article-title":"Organization of noradrenergic efferents to arousal-related basal forebrain structures","volume":"496","author":"Espa\u00f1a","year":"2006","journal-title":"J.\u00a0Comp. Neurol."},{"key":"10.1016\/j.neuropharm.2012.07.005_bib25","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0006-8993(94)91570-9","article-title":"Regional extracellular norepinephrine responses to amphetamine and cocaine and effects of clonidine pretreatment","volume":"654","author":"Florin","year":"1994","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2012.07.005_bib26","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0022-3565(25)10561-2","article-title":"Effects of reserpine on extracellular caudate dopamine and hippocampus norepinephrine responses to amphetamine and cocaine: mechanistic and behavioral considerations","volume":"274","author":"Florin","year":"1995","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2012.07.005_bib27","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1152\/physrev.1983.63.3.844","article-title":"Nucleus locus ceruleus: new evidence of anatomical and physiological specificity","volume":"63","author":"Foote","year":"1983","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.neuropharm.2012.07.005_bib28","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.jaac.2010.06.015","article-title":"Methylphenidate and atomoxetine enhance prefrontal function through alpha2-adrenergic and dopamine D1 receptors","volume":"49","author":"Gamo","year":"2010","journal-title":"J.\u00a0Am. Acad. Child. Adolesc. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.07.005_bib29","series-title":"Stimulant Drugs and ADHD: Basic and Clinical Neuroscience","first-page":"31","article-title":"Clinical effects of stimulant medication in ADHD","author":"Greenhill","year":"2001"},{"key":"10.1016\/j.neuropharm.2012.07.005_bib30","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1124\/jpet.108.145813","article-title":"Assessment of reinforcing effects of benztropine analogs and their effects on cocaine self-administration in rats: comparisons with monoamine uptake inhibitors","volume":"329","author":"Hiranita","year":"2009","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2012.07.005_bib31","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/S0022-3565(24)37956-X","article-title":"Novel 3alpha-diphenylmethoxytropane analogs: selective dopamine uptake inhibitors with behavioral effects distinct from those of cocaine","volume":"288","author":"Katz","year":"1999","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2012.07.005_bib32","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1124\/jpet.103.060525","article-title":"Effects of N-substituted analogs of benztropine: diminished cocaine-like effects in dopamine transporter ligands","volume":"309","author":"Katz","year":"2004","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2012.07.005_bib33","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1037\/0735-7044.103.5.956","article-title":"Double dissociation of egocentric and allocentric space following medial prefrontal and parietal cortex lesions in the rat","volume":"103","author":"Kesner","year":"1989","journal-title":"Behav. Neurosci."},{"key":"10.1016\/j.neuropharm.2012.07.005_bib34","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1523\/JNEUROSCI.15-02-01308.1995","article-title":"Hippocampus norepinephrine, caudate dopamine and serotonin, and behavioral responses to the stereoisomers of amphetamine and methamphetamine","volume":"15","author":"Kuczenski","year":"1995","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.07.005_bib35","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S0022-3565(24)36876-4","article-title":"Extracellular dopamine and amphetamine after systemic amphetamine administration: comparison to the behavioral response","volume":"282","author":"Kuczenski","year":"1997","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2012.07.005_bib36","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.neuroscience.2005.09.031","article-title":"Noradrenergic modulation of cognitive function in rat medial prefrontal cortex as measured by attentional set shifting capability","volume":"137","author":"Lapiz","year":"2006","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2012.07.005_bib37","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1124\/jpet.105.084541","article-title":"Place conditioning and locomotor effects of N-substituted, 4\u2032,4\u2032-difluorobenztropine analogs in rats","volume":"313","author":"Li","year":"2005","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2012.07.005_bib38","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1124\/mol.107.039800","article-title":"Relationship between conformational changes in the dopamine transporter and cocaine-like subjective effects of uptake inhibitors","volume":"73","author":"Loland","year":"2008","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2012.07.005_bib39","series-title":"Stimulant Drugs and ADHD: Basic and Clinical Neuroscience","first-page":"303","article-title":"Comparative psycholpharmacology of methylphenidate and related drugs in human volunteers, patients with ADHD, and experimental animals","author":"Mehta","year":"2001"},{"key":"10.1016\/j.neuropharm.2012.07.005_bib40","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1469-7610.2004.00221.x","article-title":"Methylphenidate improves working memory and set-shifting in AD\/HD: relationships to baseline memory capacity","volume":"45","author":"Mehta","year":"2004","journal-title":"J.\u00a0Child Psychol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.07.005_bib41","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1002\/hipo.20799","article-title":"Damage of GABAergic neurons in the medial septum impairs spatial working memory and extinction of active avoidance: effects on proactive interference","volume":"21","author":"Pang","year":"2011","journal-title":"Hippocampus"},{"key":"10.1016\/j.neuropharm.2012.07.005_bib42","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s11095-005-2488-8","article-title":"Pharmacodynamic assessment of the benztropine analogues AHN-1055 and AHN-2005 using intracerebral microdialysis to evaluate brain dopamine levels and pharmacokinetic\/pharmacodynamic modeling","volume":"22","author":"Raje","year":"2005","journal-title":"Pharm. Res."},{"key":"10.1016\/j.neuropharm.2012.07.005_bib43","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1177\/070674370200601S07","article-title":"Responses to methylphenidate in attention-deficit\/hyperactivity disorder and normal children: update 2002","volume":"6","author":"Rapoport","year":"2002","journal-title":"J.\u00a0Attention. Disord."},{"key":"10.1016\/j.neuropharm.2012.07.005_bib44","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1146\/annurev.neuro.051508.135535","article-title":"The neuropsychopharmacology of fronto-executive function: monoaminergic modulation","volume":"32","author":"Robbins","year":"2009","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2012.07.005_bib45","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1523\/JNEUROSCI.18-07-02697.1998","article-title":"Dopamine axon varicosities in the prelimbic division of the rat prefrontal cortex exhibit sparse immunoreactivity for the dopamine transporter","volume":"18","author":"Sesack","year":"1998","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.07.005_bib46","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.neuroscience.2004.12.037","article-title":"Orexin-saporin lesions of the medial septum impair spatial memory","volume":"132","author":"Smith","year":"2005","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2012.07.005_bib47","series-title":"Stimulant Drugs and ADHD: Basic and Clinical Neuroscience","first-page":"3","article-title":"Attention-deficit\/hyperactivity disorder","author":"Solanto","year":"2001"},{"key":"10.1016\/j.neuropharm.2012.07.005_bib48","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.biopsych.2011.12.002","article-title":"Psychostimulants act within the prefrontal cortex to improve cognition function","volume":"72","author":"Spencer","year":"2012","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.07.005_bib49","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1007\/s00213-004-1993-5","article-title":"Neurocognitive effects of methylphenidate in adult attention-deficit\/hyperactivity disorder","volume":"178","author":"Turner","year":"2005","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2012.07.005_bib50","doi-asserted-by":"crossref","first-page":"14494","DOI":"10.1073\/pnas.95.24.14494","article-title":"Selective effects of methylphenidate in attention deficit hyperactivity disorder: a functional magnetic resonance study","volume":"95","author":"Vaidya","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.neuropharm.2012.07.005_bib51","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1001\/jama.292.5.619","article-title":"Attention-deficit\/hyperactivity disorder in adults","volume":"292","author":"Wilens","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.neuropharm.2012.07.005_bib52","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1007\/s002130050012","article-title":"3\u2032- and 4\u2032-chloro-substituted analogs of benztropine: intravenous self-administration and in\u00a0vitro radioligand binding studies in rhesus monkeys","volume":"147","author":"Woolverton","year":"2000","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2012.07.005_bib53","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s002130000616","article-title":"Further studies of the reinforcing effects of benztropine analogs in rhesus monkeys","volume":"154","author":"Woolverton","year":"2001","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2012.07.005_bib54","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1046\/j.1471-4159.1998.71010274.x","article-title":"Regulation of extracellular dopamine by the norepinephrine transporter","volume":"71","author":"Yamamoto","year":"1998","journal-title":"J.\u00a0Neurochem."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390812003358?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390812003358?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T21:18:39Z","timestamp":1743715119000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390812003358"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":54,"alternative-id":["S0028390812003358"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2012.07.005","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]}}}